3926 - 3950 of 8620 Results
Title
Year
- Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats2014OPENTitle: Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 ratsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 505End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.011Best OA location URL: https://uvadoc.uva.es/handle/10324/63882Citation Count: 47
-
OPENTitle: Normative data for subcortical regional volumes over the lifetime of the adult human brainJournal Name: NeuroImagePublisher: Elsevier BVVol: 137Issue #:Start Page: 9End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuroimage.2016.05.016Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S1053811916301355?via%3DihubCitation Count: 127
- Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications2023OPENTitle: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.91645Best OA location URL: https://doi.org/10.7554/elife.91645Citation Count: 43
-
OPENTitle: USP30 sets a trigger threshold for PINK1–PARKIN amplification of mitochondrial ubiquitylationJournal Name: Life Science AlliancePublisher: Life Science Alliance, LLCVol: 3Issue #: 8Start Page: e202000768End Page: e202000768Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.26508/lsa.202000768Best OA location URL: https://www.life-science-alliance.org/content/lsa/3/8/e202000768.full.pdfCitation Count: 105
-
RESTRICTEDTitle: Stereotyped Relationship Between Motor and Cognitive Metabolic Networks in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2247End Page: 2256Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29188Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9669200Citation Count: 15
-
OPENTitle: PARKIN, PINK1, and DJ1 analysis in early-onset Parkinson’s disease in IrelandJournal Name: Irish Journal of Medical Science (1971 -)Publisher: Springer Science and Business Media LLCVol: 191Issue #: 2Start Page: 901End Page: 907Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11845-021-02563-wBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9376961Citation Count: 12
- Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease2019OPENTitle: Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1354End Page: 1364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27806Best OA location URL: https://escholarship.org/content/qt5c21d8ds/qt5c21d8ds.pdfCitation Count: 108
- A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells2023OPENTitle: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed CellsJournal Name: Angewandte Chemie International EditionPublisher: WileyVol: 62Issue #: 40Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/anie.202309306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.202309306Citation Count: 9
- Chemoproteomic-enabled characterization of small GTPase Rab1a as a target of an N-arylbenzimidazole ligand's rescue of Parkinson's-associated cell toxicity2021OPENTitle: Chemoproteomic-enabled characterization of small GTPase Rab1a as a target of an N-arylbenzimidazole ligand's rescue of Parkinson's-associated cell toxicityJournal Name: RSC Chemical BiologyPublisher: Royal Society of Chemistry (RSC)Vol: 3Issue #: 1Start Page: 96End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d1cb00103eBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2022/cb/d1cb00103eCitation Count: 11
- Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestoration2010OPENTitle: Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestorationJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1370Issue #:Start Page: 80End Page: 88Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.11.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3019295Citation Count: 41
-
OPENTitle: Functional connectivity disruptions correlate with cognitive phenotypes in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 14Issue #:Start Page: 591End Page: 601Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.03.002Best OA location URL: https://doi.org/10.1016/j.nicl.2017.03.002Citation Count: 100
-
OPENTitle: Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's diseaseJournal Name: Human Brain MappingPublisher: WileyVol: 36Issue #: 8Start Page: 2980End Page: 2995Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.22822Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/f5e24699-93e4-49fc-a6e3-c3d92fd2d0b9Citation Count: 108
-
OPENTitle: A Bayesian mathematical model of motor and cognitive outcomes in Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 6Start Page: e0178982End Page: e0178982Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0178982Best OA location URL: https://escholarship.org/content/qt09j8x8r1/qt09j8x8r1.pdfCitation Count: 15
- Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy2023OPENTitle: Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 187Issue #:Start Page: 106287End Page: 106287Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2023.106287Best OA location URL: https://doi.org/10.1016/j.nbd.2023.106287Citation Count: 9
- Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher Disease2021OPENTitle: Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher DiseaseJournal Name: CellsPublisher: MDPI AGVol: 10Issue #: 9Start Page: 2286End Page: 2286Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells10092286Best OA location URL: https://www.mdpi.com/2073-4409/10/9/2286/pdf?version=1630925823Citation Count: 13
-
OPENTitle: Chronotype, sleep, and sleepiness in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 106Issue #:Start Page: 105189End Page: 105189Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.011Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.10.011Citation Count: 8
-
OPENTitle: Functional Brain Networks to Evaluate Treatment Responses in Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 20Issue #: 6Start Page: 1653End Page: 1668Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1007/s13311-023-01433-wBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10684458Citation Count: 1
-
OPENTitle: SMPD1 mutations, activity, and α‐synuclein accumulation in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 4Start Page: 526End Page: 535Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27642Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6469643Citation Count: 101
- Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation in Parkinson’s disease (randomized controlled trial)2022OPENTitle: Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation in Parkinson’s disease (randomized controlled trial)Journal Name: TrialsPublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13063-022-06160-9Best OA location URL: https://trialsjournal.biomedcentral.com/track/pdf/10.1186/s13063-022-06160-9Citation Count: 7
- Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson’s disease.2022OPENTitle: Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 36Issue #: 4Start Page: 266End Page: 278Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1037/neu0000795Best OA location URL: https://psyarxiv.com/zvqge/downloadCitation Count: 5
-
RESTRICTEDTitle: Virtual Compound Screening for Discovery of Dopamine D1 Receptor Biased Allosteric ModulatorsJournal Name: Journal of Chemical Information and ModelingPublisher: American Chemical Society (ACS)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jcim.5c00972Citation Count: 0
-
OPENTitle: Lipid pathway dysfunction is prevalent in patients with Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 10Start Page: 3472End Page: 3487Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac176Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awac176/45231989/awac176.pdfCitation Count: 75
-
OPENTitle: An application of generalized matrix learning vector quantization in neuroimagingJournal Name: Computer Methods and Programs in BiomedicinePublisher: Elsevier BVVol: 197Issue #:Start Page: 105708End Page: 105708Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.cmpb.2020.105708Best OA location URL: https://doi.org/10.1016/j.cmpb.2020.105708Citation Count: 16
-
OPENTitle: Genetic Testing in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1384End Page: 1396Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29500Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29500Citation Count: 17
-
RESTRICTEDTitle: Validation of Fox Insight Cohort via Virtual Research Visits (4749)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4749Citation Count: 1